Wong Amelia F, Otillio Jaime K, Fahnestock Abby K, Smith Christine M, DeBaun Michael R, Volanakis Emmanuel, Noffsinger Lacey, Byrd Jeannie, Frazier S Barron
From the Division of Emergency Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tenn.
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tenn.
Pediatr Qual Saf. 2025 Jun 4;10(3):e821. doi: 10.1097/pq9.0000000000000821. eCollection 2025 May-Jun.
Pain episodes are the most common emergency department (ED) presentation for patients with sickle cell disease (SCD). Prompt pain medication and frequent pain assessments are recommended. Our SMART aim was to reduce the time from ED rooming to first analgesia administration for children presenting with SCD pain from 50 to less than 30 minutes by June 2024.
Children presenting to the ED with a diagnosis of SCD requiring opioids for pain were included. The primary outcome was time from rooming to analgesia. A key driver diagram, developed by a multidisciplinary team, informed our interventions and then implemented through plan-do-study-act cycles. Statistical process control charts were used to analyze data with Nelson rules to detect special cause variation. Secondary measures included frequency of pain assessments in the first 2 hours and ED length of stay.
From July 2020 to June 2024, there were 447 eligible encounters. Baseline data (n = 143) revealed an average time from ED rooming to analgesia of 50 minutes. Following interventions, including order set implementation, multidisciplinary collaboration, and incorporating the home action plan in the ED, special cause variation was detected with a centerline shift to 32 minutes. The median number of pain assessments in the first 2 hours of arrival improved from 2.2 to 2.7 with order set utilization. ED length of stay remained unchanged.
Standardizing care with an order set increased the number of pain assessments. Incorporation of the SCD home pain action plan into the ED treatment pathway decreased the time to analgesia.
疼痛发作是镰状细胞病(SCD)患者最常见的急诊科就诊原因。建议及时给予止痛药物并频繁进行疼痛评估。我们的明确目标是到2024年6月,将SCD疼痛患儿从进入急诊室到首次给予镇痛药物的时间从50分钟缩短至30分钟以内。
纳入到急诊科就诊、诊断为SCD且需要使用阿片类药物止痛的儿童。主要结局是从进入急诊室到给予镇痛药物的时间。一个由多学科团队制定的关键驱动因素图为我们的干预措施提供了依据,然后通过计划-执行-研究-行动循环予以实施。使用统计过程控制图和纳尔逊规则分析数据,以检测特殊原因变异。次要指标包括就诊后前2小时内疼痛评估的频率以及急诊留观时间。
2020年7月至2024年6月,共有447次符合条件的就诊。基线数据(n = 143)显示,从进入急诊室到给予镇痛药物的平均时间为50分钟。采取包括实施医嘱集、多学科协作以及将家庭行动计划纳入急诊科治疗等干预措施后,检测到特殊原因变异,中心线移至32分钟。使用医嘱集后,就诊后前2小时内疼痛评估的中位数从2.2次提高到2.7次。急诊留观时间保持不变。
使用医嘱集规范护理增加了疼痛评估的次数。将SCD家庭疼痛行动计划纳入急诊科治疗路径缩短了给予镇痛药物的时间。